Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
BelgiumA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
BelgiumStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
BelgiumStudy of mRNA-based seasonal influenza vaccine to evaluate immune response and safety in adults 18 years and older
BelgiumStudy of H5N8 influenza vaccine in adults previously vaccinated with H5N1/MF59 vaccine compared to those never vaccinated with H5 vaccine
BelgiumStudy of testosterone supplementation to improve quality of life in male patients receiving palliative care who have androgen deficiency
BelgiumLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
BelgiumStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
BelgiumStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
BelgiumStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
BelgiumStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
